# FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)

> **NCT01065779** · — · COMPLETED · sponsor: **Organon and Co** · enrollment: 880 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** FOSAMAX PLUS
- **DRUG:** FOSAMAX PLUS D

## Key facts

- **NCT ID:** NCT01065779
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 880 (ACTUAL)
- **Last updated:** 2022-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01065779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01065779, "FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01065779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*